ArticleResearch square2024
Scalable analysis of large multi-ancestry biobanks by leveraging sparse ancestry-adjusted sample-relatedness.
Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Linear mixed-effects models (LMMs) and ridge regression are commonly applied in genetic association studies to control for population structure and sample-relatedness. To control for sample-relatedness, the existing methods use empirical genetic relatedness matrices (GRM) either explicitly or conceptually. This works well with mostly homogeneous populations, however, in multi-ancestry heterogeneous populations, GRMs are confounded with population structure which leads to inflated type I error rates, massively increased computation, and reduced power. Here, we propose FastSparseGRM, a scalable pipeline for multi-ancestry Genome-Wide Association studies (GWAS) and Whole Genome Sequencing (WGS) studies. It utilizes a block-diagonal sparse ancestry-adjusted (BDSA) GRM to model sample-relatedness, and ancestry PCs as fixed effects to control for population structure. It is ~ 2540/4100/54 times faster than BOLT-LMM/fast-GWA/REGENIE for fitting the null LMM on 50,000 heterogeneous subjects. Through numerical simulations and both single-variant GWAS and rare variant WGS analyses of five biomarkers (Triglycerides, HDL, LDL, BMI, Total Bilirubin) on the entire UK Biobank data, we demonstrate that our approach scales to nearly half-a-million subjects and provides accurate p-value calibration and improved power compared to the existing methods.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.